SkinHealth Systems Inc.

Good morning and welcome to the Beauty Health Company second quarter 2023 earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then 2. Please note this event is being recorded. I would now like to turn the conference over to Eduardo Rodriguez, Senior Director of M&A and Investor Relations.

Please go ahead. Thank you, Operator, and good morning, everyone. Thank you for joining the Beauty Health Company's conference call to discuss our second quarter 2023 financial results, which were released this morning and can be found on our website at beautyhealth.com. We encourage you to join the webcast accessible on our website, which contains a presentation that will be referenced during this call. With me in person today are Beauty Health's President and Chief Executive Officer, Andrew Stanlick, incoming Chief Financial Officer, Mike Monahan, and Chief Operating Officer, Brad Hauser. Before we begin, I would like to remind you of the company's Safe Harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. Listeners are cautioned not to place undue reliance on any forward-looking statements. For a further discussion of risks related to our business, see our filings with the SEC. This call will present non-GAAP financial measures. Reconciliation of these non-GAAP measures to the most comparable GAAP measures are in the earnings release furnished to the SEC and available on our website. I will now turn the call over to Andrew.

Thank you, Eduardo, and thank you, everyone, for joining us. Today's call is going to be organized a bit different than usual. First, we'll review the highlights of our Q2 results before turning to some key learnings and actions taken through this period of rapid growth. I will then walk you through our 2023 outlook, and we will conclude with a preview of our innovation pipeline from Chief Operating Officer Brad Houser. We expect you saw the press release this morning announcing Michael Monaghan as our new CFO. This is a critical role and I'm confident that Mike brings the right expertise that we need for this next phase of growth. I am tasking Mike with enhancing our financial strategy, planning and reporting capabilities. To that end, I do want to thank Leanne for her leadership during a formative period for Beauty Health. She helped manage the company through a period of transformational growth, including navigating through the pandemic. We are grateful for her contribution and wish her well. Mike will assume the role of CFO effective tomorrow. Leanne will stay on as an advisor until September 1st to ensure a smooth transition. I will now hand off to Mike for a brief introduction.